Literature DB >> 9488000

Islet cell proliferation and apoptosis in insulin-like growth factor binding protein-1 in transgenic mice.

S T Dheen1, K Rajkumar, L J Murphy.   

Abstract

Transgenic mice which overexpress insulin-like growth factor binding protein-1 (IGFPB-1) demonstrate fasting hyperglycemia, hyperinsulinemia and glucose intolerance in adult life. Here we have examined the ontogeny of pancreatic endocrine dysfunction and investigated islet cell proliferation and apoptosis in this mouse model. In addition we have examined pancreatic insulin content in transgenic mice derived from blastocyst transfer into non-transgenic mice. Transgenic mice were normoglycemic at birth but had markedly elevated plasma insulin levels, 56.2 +/- 4.5 versus 25.4 +/- 1.5 pmol/l, p < 0.001, and pancreatic insulin concentration, 60.5 +/- 2.5 versus 49.0 +/- 2.6 ng/mg of tissue, P < 0.01, compared with wild-type mice. Transgenic mice derived from blastocyst transfer to wild-type foster mothers had an elevated pancreatic insulin content similar to that seen in pups from transgenic mice. There was an age-related decline in pancreatic insulin content and plasma insulin levels and an increase in fasting blood glucose concentrations, such that adult transgenic mice had significantly less pancreatic insulin than wild-type mice. Pancreatic islet number and the size of mature islets were increased in transgenic animals at birth compared with wild-type mice. Both islet cell proliferation, measured by 5-bromo-2'-deoxyuridine labeling, and apoptosis, assessed by the in situ terminal deoxynucleotidyl transferase and nick translation assay, were increased in islets of newborn transgenic mice compared with wild-type mice. In adult mice both islet cell proliferation and apoptosis were low and similar in transgenic and wild-type mice. Islets remained significantly larger and more numerous in adult transgenic mice despite a reduction in pancreatic insulin content. These data suggest that overexpression of IGFBP-1, either directly or indirectly via local or systemic mechanisms, has a positive trophic effect on islet development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9488000     DOI: 10.1677/joe.0.1550551

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

Review 1.  Functional consequences of IGFBP excess-lessons from transgenic mice.

Authors:  Eckhard Wolf; Marlon R Schneider; Rui Zhou; Thomas M Fisch; Nadja Herbach; Maik Dahlhoff; Rüdiger Wanke; Andreas Hoeflich
Journal:  Pediatr Nephrol       Date:  2004-12-16       Impact factor: 3.714

2.  Sustained insulin secretory response in human islets co-cultured with pancreatic duct-derived epithelial cells within a rotational cell culture system.

Authors:  H E Murray; M B Paget; C J Bailey; R Downing
Journal:  Diabetologia       Date:  2009-01-08       Impact factor: 10.122

3.  Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice.

Authors:  Julia I Leu; Mary Ann S Crissey; Rebecca Taub
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

4.  Effects of acute and chronic psychological stress on isolated islets' insulin release.

Authors:  Homeira Zardooz; Saleh Zahediasl; Fatemeh Rostamkhani; Babak Farrokhi; Shiva Nasiraei; Behrang Kazeminezhad; Roohollah Gholampour
Journal:  EXCLI J       Date:  2012-04-23       Impact factor: 4.068

Review 5.  The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes.

Authors:  Natalie J Haywood; Thomas A Slater; Connor J Matthews; Stephen B Wheatcroft
Journal:  Mol Metab       Date:  2018-10-24       Impact factor: 7.422

6.  Beta-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform.

Authors:  Oscar Escribano; Carlos Guillén; Carmen Nevado; Almudena Gómez-Hernández; C Ronald Kahn; Manuel Benito
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

7.  IGFBP1 increases β-cell regeneration by promoting α- to β-cell transdifferentiation.

Authors:  Jing Lu; Ka-Cheuk Liu; Nadja Schulz; Christos Karampelias; Jérémie Charbord; Agneta Hilding; Linn Rautio; Philippe Bertolino; Claes-Göran Östenson; Kerstin Brismar; Olov Andersson
Journal:  EMBO J       Date:  2016-08-11       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.